Search
01/12/2021
Recreational Drug Use in People Living with HIV in Spain: Factors Associated with Drug Use and the Impact on Clinical Outcomes
Castro-Granell, V, Garin, N, Jaen, A, Casado, JL, Leal, L, Cenoz, S, Fuster-RuizdeApodaca, MJ. Recreational Drug Use in People Living with HIV in Spain: Factors Associated with Drug Use and the Impact on Clinical Outcomes. AIDS AND BEHAVIOR. 2021; 25(12)DOI:10.1007/s10461-021-03271-3. PMID:33932187. IF:4.852(Q1/2D).
01/12/2021
The Impact of Pharmaceutical Care in Multidisciplinary Teams on Health Outcomes: Systematic Review and Meta-Analysis
Hernandez, MH, Juanes-Borrego, AM, Mila, R, Mangues-Bafalluy, MA, Mestres, C. The Impact of Pharmaceutical Care in Multidisciplinary Teams on Health Outcomes: Systematic Review and Meta-Analysis. Journal of the American Medical Directors Association. 2021; 22(12)DOI:10.1016/j.jamda.2021.05.0381525-8610. PMID:34228962. IF:7.802(Q1/2D).
01/12/2021
Antimicrobial stewardship programs in emergency departments: how do we measure antimicrobial use? A systematic review
Ruiz-Ramos, J, Alcon, EV, Ramos, FM, Santolaya-Perrin, R, Tey, JMG. Antimicrobial stewardship programs in emergency departments: how do we measure antimicrobial use? A systematic review. Revista Espanola de Quimioterapia. 2021; 34(6)DOI:10.37201/req/028.2021. PMID:34523327. IF:2.515(Q3/8D).
01/12/2021
Efficacy of Dupilumab in Atopic Dermatitis: The Patient's Perspective
de Bruin-Weller, M, Merola, JF, Hong, CH, Baldrich, ES, Ettler, K, Sierka, D, Delevry, D, Chen, Z, Rossi, AB. Efficacy of Dupilumab in Atopic Dermatitis: The Patient's Perspective. Dermatology and Therapy. 2021; 11(6)DOI:10.1007/s13555-021-00621-w. PMID:34767181. IF:3.661(Q2/3D).
01/12/2021
Long-term efficacy and safety of risankizumab for the treatment of moderate-to-severe plaque psoriasis: interim analysis of the LIMMitless open-label extension trial beyond 3 years of follow-up
Papp, KA, Lebwohl, MG, Puig, L, Ohtsuki, M, Beissert, S, Zeng, J, Rubant, S, Sinvhal, R, Zhao, Y, Soliman, AM, Alperovich, G, Leonardi, C. Long-term efficacy and safety of risankizumab for the treatment of moderate-to-severe plaque psoriasis: interim analysis of the LIMMitless open-label extension trial beyond 3 years of follow-up. BRITISH JOURNAL OF DERMATOLOGY. 2021; 185(6)DOI:10.1111/bjd.20595. PMID:34157132. IF:11.113(Q1/1D).
01/12/2021
Integra as Firstline Treatment for Scalp Reconstruction in Elderly Patients
Mogedas-Vegara, A, Agut-Busquet, E, Marsal, MY, Aguilar, JL, de la Torre, OE. Integra as Firstline Treatment for Scalp Reconstruction in Elderly Patients. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY. 2021; 79(12)DOI:10.1016/j.joms.2021.07.009. PMID:34391723. IF:2.136(Q4/8D).